These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6231780)

  • 1. [Current dosed aerosols in the treatment of obstructive airway diseases. 2. Bronchospasmolytics].
    Krecklow B
    Z Arztl Fortbild (Jena); 1984; 78(1):5-9. PubMed ID: 6231780
    [No Abstract]   [Full Text] [Related]  

  • 2. [Onset of action and maximum effect of bronchodilators administered by a metered dose inhaler. Clinical investigations with fenoterol, hexoprenaline, ipratropium bromide, isoprenaline, orciprenaline, salbutamol and terbutaline (author's transl)].
    Kaik G
    Wien Klin Wochenschr; 1976 Oct; 88(20):674-9. PubMed ID: 136813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The validation and procedure of inhalation therapy using 2-component aerosols in obstructive bronchopulmonary diseases].
    Ivashkin VT; Iakovlev VN; Sinopal'nikov AI; Antokhin EA
    Ter Arkh; 1993; 65(8):44-9. PubMed ID: 8211802
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of dosage-aerosols in the treatment of obstructive respiratory tract diseases].
    Frank A
    Wien Med Wochenschr; 1977 May; 127(10):309-13. PubMed ID: 141791
    [No Abstract]   [Full Text] [Related]  

  • 5. [Basic medication of chronic obstructive lung disease with berodual].
    Melent'eva EM
    Klin Med (Mosk); 1999; 77(7):47-8. PubMed ID: 10483166
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of nebulized ipratropium bromide in acute exacerbation of early chronic obstructive airway disease.
    Bharthwal MS
    J Assoc Physicians India; 2000 Mar; 48(3):363. PubMed ID: 11229133
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of aerosol treatment with spasmolytic agents of obstructive bronchitis in infancy and early childhood].
    Tatotschenko WK; Schirjajewa IS; Tarasenko TD; Batyrchanow SK; Reutowa WS; Dorochowa NP; Krolik EB
    Z Erkr Atmungsorgane; 1988; 171(2):168-74. PubMed ID: 2977027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Broncholytic activity of dose-adjusted aerosols in active respiratory tuberculosis].
    Vizel' AA; Iaushev MF; Mustafin RR; Goncharova LV
    Probl Tuberk; 1995; (2):7-9. PubMed ID: 7777469
    [No Abstract]   [Full Text] [Related]  

  • 9. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Are changes in airway resistance revealed by the pneumosonogram sufficiently specific?].
    Cegla UH; Navarro C
    Med Klin; 1981 May; 76(11):324-5. PubMed ID: 6454059
    [No Abstract]   [Full Text] [Related]  

  • 11. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?].
    Musil J; Hirsch V; Vondra V; Reisová M
    Vnitr Lek; 1998 Jul; 44(7):415-7. PubMed ID: 9748878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral therapy with beta-2-sympathomimetic drugs: comparative study of the bronchospasmolytic effect of tulobuterol and fenoterol in patients with reversible airway obstruction].
    Morr H; Nink M; Ferlinz R
    Pneumologie; 1990 Apr; 44(4):739-43. PubMed ID: 2192369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the method of inhalation of Berodual on bronchodilation in patients over 60 years of age with diffuse bronchial obstruction].
    Czernicka-Cierpisz E; Kościńska M; Radomyski A; Sliwiński P; Zieliński J
    Pneumonol Pol; 1988 Oct; 56(10):486-91. PubMed ID: 2978275
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies on the effectiveness of inhalant beta 2 mimetics therapy in patients with obstructive respiratory disorders].
    Würtemberger G; Weil R; Schulte-Mönting J; Matthys H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():304-6. PubMed ID: 2902608
    [No Abstract]   [Full Text] [Related]  

  • 15. [New developments in the field of bronchospasmolytics].
    Nolte D
    Clin Ter; 1980 Jan; 92(1):3-13. PubMed ID: 7449306
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is nebulized ipratropium bromide effective in the treatment of exacerbations of chronic obstructive pulmonary disease?].
    Musil J
    Vnitr Lek; 2000 Jan; 46(1):45-8. PubMed ID: 10953664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Improved inhaler confirmed in general practice. Patients with respiratory diseases can breathe freely].
    MMW Fortschr Med; 2006 Dec; 148(49-50):52. PubMed ID: 17619331
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical study on carbuterol (SKF 40383), a new selective bronchodilator agent aerosol: double blind comparison with isoproterenol aerosol.
    Saleeby PR; Ziskind MM
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):225-33. PubMed ID: 805017
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of pressure-packed bornchodilator aerosols in chronic obstructive bronchitis.
    Chatterjee SS; Dinda P; Riding WD
    Scand J Respir Dis; 1971; 52(2):71-6. PubMed ID: 5170643
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bronchodilator treatment of COPD].
    Naberan K
    Aten Primaria; 1998 Feb; 21(2):109-13. PubMed ID: 9608136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.